Please find attached intimation w.r.t. Dividend
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.0 pts less than Nifty Microcap 250 and 6.5 pts less than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bombay Oxygen Investments (a Non-Banking Financial Company focused on investments) reported audited results for FY ended 31 March 2025 along with Q4 figures. Total income for FY25 fell sharply to Rs. 2,090.39 lakhs from Rs. 7,221.60 lakhs in FY24, mainly because net gain on fair value changes of investments dropped to Rs. 1,264.79 lakhs vs Rs. 6,880.98 lakhs last year. Profit before tax was Rs. 1,907.65 lakhs (vs Rs. 7,022.10 lakhs) and net profit was Rs. 1,750.59 lakhs (vs Rs. 5,760.09 lakhs), translating to EPS of Rs. 1,167.06 vs Rs. 3,840.06. The Board has recommended a dividend of Rs. 35 per share (35%) on the Rs. 100 face value, higher than last year's Rs. 25 per share, subject to shareholder approval at the 64th AGM on 15 July 2025. The Board also appointed M/s SCP & Co as Secretarial Auditor for 5 years and re-appointed Ms. Hema Renganathan as Whole-Time Director for 2 years from 1 July 2025. The statutory auditor issued an unqualified opinion on the results.
Despite a steep year-on-year fall in earnings driven by lower mark-to-market gains on its investment portfolio (book value ~Rs. 500 crore), the higher dividend signals management's confidence in distributing returns to shareholders. Short-term PAT decline may weigh on sentiment, but the clean audit report and steady dividend hike are supportive for income-focused investors.